CARv3-TEAM-E T Cells in Glioblastoma

Clinical trial NCT05660369 · RECRUITING

Trial details

NCT number: NCT05660369
Sponsor: Marcela V. Maus, M.D.,Ph.D.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Malignant Glioma Recurrent Glioblastoma Recurrent Glioma

Start date: 2023-03-22
Primary completion: 2026-09-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.